132 related articles for article (PubMed ID: 1836682)
1. Fibrinolytic parameters and lipoprotein (a) levels in plasma of patients with coronary artery disease.
García Frade LJ; Alvarez JJ; Rayo I; Torrado MC; Lasunción MA; García Avello A; Hernandez A; Marín E
Thromb Res; 1991 Aug; 63(4):407-18. PubMed ID: 1836682
[TBL] [Abstract][Full Text] [Related]
2. Plasma lipoprotein(a) levels and fibrinolytic activity in patients with unstable angina.
Okubo H; Yasue H; Ogawa H; Misumi I; Masuda T; Miyao Y; Sakamoto T
Jpn Circ J; 1993 Oct; 57(10):947-54. PubMed ID: 7901435
[TBL] [Abstract][Full Text] [Related]
3. Tissue plasminogen activator and other risk factors as predictors of cardiovascular events in patients with severe angina pectoris.
Jansson JH; Nilsson TK; Olofsson BO
Eur Heart J; 1991 Feb; 12(2):157-61. PubMed ID: 1904350
[TBL] [Abstract][Full Text] [Related]
4. The increased plasma Lp(a): B lipoprotein particle concentration in angina pectoris is not associated with hypofibrinolysis.
Alessi MC; Parra HJ; Joly P; Vu-Dac N; Bard JM; Fruchart JC; Juhan-Vague I
Clin Chim Acta; 1990 Apr; 188(2):119-27. PubMed ID: 2143123
[TBL] [Abstract][Full Text] [Related]
5. Effect of niceritrol on fibrinolysis and lipoprotein (a) levels in patients with coronary artery disease.
Suefuji H; Ogawa H; Yasue H; Imoto N; Sakamoto T; Miyao Y; Kaikita K; Soejima H; Nishiyama K
Coron Artery Dis; 1996 Feb; 7(2):167-72. PubMed ID: 8813450
[TBL] [Abstract][Full Text] [Related]
6. Transmyocardial fibrinolytic activity in patients with unstable angina pectoris.
Daniel WC; Meidell RS; Hillis LD; Lange RA
Coron Artery Dis; 1996 Jan; 7(1):45-9. PubMed ID: 8773432
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease.
Aznar J; Estellés A; Tormo G; Sapena P; Tormo V; Blanch S; España F
Br Heart J; 1988 May; 59(5):535-41. PubMed ID: 3132963
[TBL] [Abstract][Full Text] [Related]
8. [Decreased fibrinolytic capacity in coronary patients by increased plasminogen activator inhibitor activity].
Ihnken K; Speiser W; Müller-Berghaus G; Beyersdorf F; Schlepper M; Satter P
Helv Chir Acta; 1992 Jan; 58(4):503-8. PubMed ID: 1582860
[TBL] [Abstract][Full Text] [Related]
9. Plasminogen activator inhibitor activity as a possible indicator of disease activity in rest angina with angiographically insignificant coronary artery stenosis.
Sakata K; Kurata C; Kobayashi A; Rydzewski A; Yamazaki N
Thromb Res; 1991 Sep; 63(5):491-502. PubMed ID: 1755002
[TBL] [Abstract][Full Text] [Related]
10. A depression of active tissue plasminogen activator in plasma characterizes patients with unstable angina pectoris who develop myocardial infarction.
Munkvad S; Gram J; Jespersen J
Eur Heart J; 1990 Jun; 11(6):525-8. PubMed ID: 2112469
[TBL] [Abstract][Full Text] [Related]
11. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction.
Hamsten A; Wiman B; de Faire U; Blombäck M
N Engl J Med; 1985 Dec; 313(25):1557-63. PubMed ID: 3934538
[TBL] [Abstract][Full Text] [Related]
12. Plasminogen activator inhibitor-1 levels in patients with chronic angina pectoris with or without angiographic evidence of coronary sclerosis.
Huber K; Resch I; Stefenelli T; Lang I; Probst P; Kaindl F; Binder BR
Thromb Haemost; 1990 Jun; 63(3):336-9. PubMed ID: 2119522
[TBL] [Abstract][Full Text] [Related]
13. Correlations between fibrinolytic function and acute myocardial infarction.
Wiman B; Hamsten A
Am J Cardiol; 1990 Nov; 66(16):54G-56G. PubMed ID: 2122704
[TBL] [Abstract][Full Text] [Related]
14. Effects of nicorandil on endogenous fibrinolytic capacity in patients with coronary artery disease.
Sakamoto T; Kaikita K; Miyamoto S; Kojima S; Sugiyama S; Yoshimura M; Ogawa H
Circ J; 2004 Mar; 68(3):232-5. PubMed ID: 14993778
[TBL] [Abstract][Full Text] [Related]
15. Relationships between lipoprotein(a), lipids, apolipoproteins, basal and stimulated fibrinolytic regulators, and D-dimer.
Glueck CJ; Glueck HI; Tracy T; Speirs J; McCray C; Stroop D
Metabolism; 1993 Feb; 42(2):236-46. PubMed ID: 8474322
[TBL] [Abstract][Full Text] [Related]
16. The role of the fibrinolytic system in acute myocardial infarction after a normal exercise test.
Sakata K; Kurata C; Taguchi T; Hayashi H; Kobayashi A; Yamazaki N; Rydzewski A; Takada A
Eur Heart J; 1989 Dec; 10(12):1118-22. PubMed ID: 2514101
[TBL] [Abstract][Full Text] [Related]
17. Endogenous testosterone, fibrinolysis, and coronary heart disease risk in hyperlipidemic men.
Glueck CJ; Glueck HI; Stroop D; Speirs J; Hamer T; Tracy T
J Lab Clin Med; 1993 Oct; 122(4):412-20. PubMed ID: 8228555
[TBL] [Abstract][Full Text] [Related]
18. Endothelial tissue-type plasminogen activator release in coronary heart disease: Transient reduction in endothelial fibrinolytic reserve in patients with unstable angina pectoris or acute myocardial infarction.
Hoffmeister HM; Jur M; Ruf-Lehmann M; Helber U; Heller W; Seipel L
J Am Coll Cardiol; 1998 Mar; 31(3):547-51. PubMed ID: 9502633
[TBL] [Abstract][Full Text] [Related]
19. Difference in fibrinolytic activity between multivessel coronary spasm and one-vessel coronary spasm.
Ogawa H; Suefuji H; Takazoe K; Soejima H; Sakamoto T; Miyamoto S; Kaikita K; Yoshimura M; Kugiyama K; Yasue H
Am J Cardiol; 2000 Jan; 85(1):98-101, A8. PubMed ID: 11078245
[TBL] [Abstract][Full Text] [Related]
20. Changes in plasminogen activator inhibitor 1 and tissue-type plasminogen activator during exercise in patients with coronary artery disease.
Rydzewski A; Sakata K; Kobayashi A; Yamazaki N; Urano T; Takada Y; Takada A
Haemostasis; 1990; 20(5):305-12. PubMed ID: 2127039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
